Imlifidase

Name: Imlifidase in Kidney transplantation in highly sensitized patients: Dosage
Published: 2026-09-14T15:39:06-04:00

Kidney transplantation in highly sensitized patients

Manufacturer: Hansa Biopharma
Regulatory submission: BLA submitted December 2025
Launch: Anticipated in the first quarter of 2027
Last updated: September 19, 2026

Section

Product information and disease description Product description Product information Dosing and administration

Dosage

1 evidence topic · 1 source

Dose

“The recommended dose is 0.25 mg/kg administered as a single dose preferably within 24 hours before transplantation.” (opens the source at this quote in a new tab)